• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • Adenosine Kinase Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

Using TBK1 Inhibitors to Stop Cancer in Its Tracks

by Bellbrook Labs / Tuesday, 29 October 2019 / Published in Emerging Targets
Scientist Working on TBK1 Inhibitors for Cancer Research

TBK1 Inhibitors, Autoimmune Disorders, and Cancer – Inflammation is a crucial step within the immune response, helping our bodies eliminate disease. However, it can also be a burden where misregulation creates a variety of maladies including cancer. As inflammation persists, becoming chronic, the beneficial elements can be lost and disease occurs. It’s not just autoimmune disorders that lead to chronic inflammation. Researchers believe there are a range of contributors these days including chemicals, pollutants, alcohol, obesity, and chronic stress, which are all common influences in most of our lives.

Persistent inflammation drives tumor initiation and continues to play a role in tumor promotion, malignant conversion, and metastasis. Furthermore, immune mediators such as cytokines, chemokines, growth factors, and free radicals can stimulate tumor development and its microenvironment.

The Role of TBK1 in Inflammation and Cancer

Foreign DNA such as virus or bacteria alerts the immune system, but so does damaged DNA. In these instances, the “bad” DNA is in the cytosol waiting to be destroyed vs. the mitochondria or nucleus which is typically where DNA is located. This cytosolic DNA is what sets the STING (stimulator of interferon genes) signaling pathway in motion. It gets recognized by cGAS, which allows cGAMP (a cyclic di-nucleotide formed in response to double-stranded DNA (dsDNA) in the cytosol) to bind to STING.2

TBK1 is a critical player in initiating inflammation as it has the ability to regulate proteins such as IFN-β, an inflammatory mediator. When TBK1 phosphorylates STING, it becomes more accessible for the binding of IRF3. TBK1 then phosphorylates IRF3, which translocates to the nucleus to drive transcription of IFN-β.1  IFN-β expression has been found in tumor-derived DNA in the cytosol of dendritic cells.1

TBK1 Inhibitors Show Promise

Hence, targeting TBK1 to decrease inflammation when it becomes chronic is a logical choice. One in which scientists’ have already started capitalizing on as is the case of TBK1 inhibitor, BX795.3 Although progress has been made, there’s still potential in targeting TBK1 directly in order to curb inflammation and keep cancer at bay. More researchers are getting on board as chronic inflammation and cancer are significant health issues leading to fatality. According to CDC, cancer is the second leading cause of death in the US.

Since TBK1 is a protein kinase, the Transcreener ADP² Assay is ideal for measuring the activity of the enzyme, which is necessary when screening possible inhibitors for therapeutic potential. This assay can be used for high throughput screening (HTS) and hit-to-lead programs. Additionally, the technique is easy to use, safe, sensitive, and robust.

Learn More About the TBK1 Assay

References

  1. Corrales L, McWhirter SM, Dubensky TW, Gajewski TF. The host STING pathway at the interface of cancer and immunity. J Clin Invest. 2016;126(7):2404-2411. doi:10.1172/JCI86892
  2. Li T, Chen ZJ. The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med. 2018;215(5):1287-1299. doi:10.1084/jem.20180139
  3. Yu T, Yi Y-S, Yang Y, Oh J, Jeong D, Cho JY. The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages. Mediators Inflamm. 2012;2012:1-8. doi:10.1155/2012/979105
Tagged under: kinase assay, TBK1 Inhibitors, Transcreener ADP Kinase Assay

What you can read next

ABC Transporter ATPase Assay Inhibitor
ABC Transporter ATPase Assay Helps Discover MsbA Inhibitors
Unraveling RhoGDIα Regulation
BellBrook Labs Awarded NIH Grant to Develop a High Throughput cGAS Assay for Cancer and Autoimmune Disease Drug Discovery

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Scientist Studying ALKPK1

    The Role ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...
  • Researcher Studying MAPK14

    MAPK14 in Context

    MAPK14 (or p38 alpha or SAPK2a) is a proline-di...
  • PRMT5 Role with Macrophages

    PRMT5 is Innately Interesting

    PRMT5 is a type II arginine methyltransferase t...
  • IRE1 Proteins in ER

    The Multifaceted Roles of IRE1 Are Unfolding

    IRE1 (Inositol-Requiring Enzyme 1) is one of th...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2021 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP